Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Hayder M. Al-kuraishy"'
Autor:
Abdullah A. Alshehri, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Sabrean F. Jawad, Wael Y. Khawagi, Athanasios Alexiou, Marios Papadakis, Abdullah A Assiri, Heba Elhadad, Gaber El-Saber Batiha
Publikováno v:
Journal of Inflammation, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Atherosclerosis (AS) formation is enhanced by different mechanisms including cytokine generation, vascular smooth muscle cell proliferation, and migration. One of the recent treatments towards endothelial dysfunction and AS is Vinpocetine (V
Externí odkaz:
https://doaj.org/article/246f1de1aa784036bfdb20403dd79e6c
Autor:
Naif H. Ali, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Saud A. Alnaaim, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad, Gaber El-Saber Batiha
Publikováno v:
Molecular Medicine, Vol 29, Iss 1, Pp 1-19 (2023)
Abstract Autophagy is an explicit cellular process to deliver dissimilar cytoplasmic misfolded proteins, lipids and damaged organelles to the lysosomes for degradation and elimination. The mechanistic target of rapamycin (mTOR) is the main negative r
Externí odkaz:
https://doaj.org/article/f4bb536ac8b04bc49a4725e1894b426f
Autor:
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Athanasios Alexiou, Marios Papadakis, Abdulrahman A. Alsayegh, Najlaa Hamed Almohmadi, Hebatallah M. Saad, Gaber El‐Saber Batiha
Publikováno v:
Pharmacology Research & Perspectives, Vol 11, Iss 2, Pp n/a-n/a (2023)
Abstract Parkinson's disease (PD) is the second most frequent neurodegenerative brain disease (NBD) after Alzheimer's disease (AD). Statins are the most common lipid‐lowering agents used in the management of dyslipidemia and the prevention of prima
Externí odkaz:
https://doaj.org/article/a91b514b66154f9ea98a5248c67d83a9
Autor:
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Afrah Fahad Alkhuriji, Wafa Abdullah I. Al-Megrin, Engy Elekhnawy, Walaa A. Negm, Michel De Waard, Gaber El-Saber Batiha
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 154, Iss , Pp 113673- (2022)
Cardiac injury is the main dose-limiting factor for doxorubicin (Dox) use as an anticancer agent. The cardiotoxicity of Dox is linked to a number of complex mechanisms, including oxidative stress, mitochondrial damage, intracellular calcium dysregula
Externí odkaz:
https://doaj.org/article/cd7a523ec2c54fd38599a120ac462578
Autor:
Mohammed Alorabi, Simona Cavalu, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Gomaa Mostafa-Hedeab, Walaa A. Negm, Amal Youssef, Aya H. El-Kadem, Hebatallah M. Saad, Gaber El-Saber Batiha
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 152, Iss , Pp 113225- (2022)
Nephrotoxicity (NT) is a renal-specific situation caused by different toxins and drugs like non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs like diclofenac (DCF) lead to glomerular dysfunction. Pentoxifylline (PTX) and berberine (BER) have ant
Externí odkaz:
https://doaj.org/article/cbe14681b3664a08ac57fb5cf93fc4ff
Autor:
Hayder M. Al-Kuraishy, Hany A. Al-Hussaniy, Ali I. Al-Gareeb, Walaa A. Negm, Aya H. El-Kadem, Gaber El-Saber Batiha, Nermeen N. Welson, Gomaa Mostafa-Hedeab, Ahmed H Qasem, Carlos Adam Conte-Junior
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Doxorubicin (DOX) is an anticancer agent for treating solid and soft tissue malignancies. However, the clinical use of DOX is restricted by cumulative, dose-dependent cardiotoxicity. Therefore, the present study aimed to assess the cardioprotective e
Externí odkaz:
https://doaj.org/article/6d2b3891ed9e4f6fb19007790d01ad75
Autor:
Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nermeen N. Welson, Gaber El-Saber Batiha, Carlos Adam Conte-Junior
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
A novel severe acute respiratory distress syndrome coronavirus type 2 (SARS-CoV-2) has been confirmed as the cause of the global pandemic coronavirus disease 2019 (COVID-19). Different repurposed drugs have been trialed and used in the management of
Externí odkaz:
https://doaj.org/article/d18a56cda00d4a0cb58010ef689a1841
Autor:
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Francis O. Atanu, Gaber El-Saber Batiha
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 143, Iss , Pp 112193- (2021)
In Covid-19, systemic disturbances may progress due to development of cytokine storm and dysregulation of and plasma osmolarility due to high release of pro-inflammatory cytokines and neuro-hormonal disorders. Arginine vasopressin (AVP) which is invo
Externí odkaz:
https://doaj.org/article/9e5e5e7c57c34a939dd81cd5f47c2ab2
Autor:
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mohammed Alqarni, Natália Cruz-Martins, Gaber El-Saber Batiha
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Coronavirus disease 2019 (COVID-19) is a global infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 15% of severe cases require an intensive care unit (ICU) admission and mechanical ventilation due
Externí odkaz:
https://doaj.org/article/9385e1bdb24b4d1390fddb24bf694fc1
Autor:
Ali I. Al-Gareeb, Hayder M Al-Kuraishy, Francis O. Atanu, Eida M. Alshammari, Safaa Y. Qusti, Gaber El-Saber Batiha
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 143, Iss, Pp 112193-(2021)
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
In Covid-19, systemic disturbances may progress due to development of cytokine storm and dysregulation of and plasma osmolarility due to high release of pro-inflammatory cytokines and neuro-hormonal disorders. Arginine vasopressin (AVP) which is invo